Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial.

Xuewei Ding(Tianjin Medical University Cancer Institute and Hospital), Han Liang(Sun Yat-sen University), Bin Li(Tianjin Medical University Cancer Institute and Hospital), Mingzhi Cai(Tianjin Medical University Cancer Institute and Hospital), Qiang Xue(Sichuan University), Bin Ke(Tianjin Medical University Cancer Institute and Hospital), Baogui Wang(Tianjin Medical University Cancer Institute and Hospital), Jingli Cui(Tianjin Medical University Cancer Institute and Hospital), Rupeng Zhang(Second Affiliated Hospital of Xi'an Jiaotong University)
Journal of Clinical Oncology
January 19, 2022
Cited by 14


Related Papers